Atlas Trials

Bank of Human Leukocytes From COVID-19 Convalescent Donors With an Anti-SARS-CoV-2 Cellular Immunity

Clinical trial NCT05458440 · RECRUITING

Trial details

NCT number
NCT05458440
Sponsor
Central Hospital, Nancy, France
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19
Start date
2022-09-01
Primary completion
2025-12-15
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.